Search research articles
Contact Us
Filters
Showing results (111-120 of 133) with videos related to
Page
of 14
Sort By:
Endocrinology
|
June 1, 1983
Changes in tissue concentrations of thyrotropin, free thyrotropin beta, and alpha-subunits after thyroxine administration: comparison of mouse hypothyroid pituitary and thyrotropic tumors
D S Ross, M F Downing, W W Chin, et al.
Journal of Surgical Oncology
|
September 1, 1983
Gut-associated lymphoid tissue and dimethylhydrazine-induced colorectal carcinoma in the Wistar/Furth rat
J M Deasy, G Steele, D S Ross, et al.
Endocrinology
|
November 1, 1983
Mouse pituitary tumor line secreting only the alpha-subunit of the glycoprotein hormones: development from a thyrotropic tumor
E C Ridgway, J D Kieffer, D S Ross, et al.
Surgery
|
November 1, 1990
Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements
J A Riseman, W A Zamboni, A Curtis, et al.
Calcified Tissue International
|
November 4, 1998
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates
H N Rosen, A C Moses, J Garber, et al.
The Journal of Biological Chemistry
|
December 25, 1983
Regulation by thyroxine of the mRNA encoding the alpha subunit of mouse thyrotropin
M A Shupnik, W W Chin, D S Ross, et al.
Radiology
|
June 1, 1993
Fine-needle biopsy of cervical lymph nodes in patients with thyroid cancer: a prospective comparison of cytopathologic and tissue marker analysis
M J Lee, D S Ross, P R Mueller, et al.
JBI Evidence Implementation
|
December 28, 2023
Factors that influence the implementation of innovation in aged care: a scoping review
Alice Windle, Amy Marshall, Lenore de la Perrelle, et al.
Calcified Tissue International
|
February 1, 2000
Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy
H N Rosen, A C Moses, J Garber, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 14, 1998
Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate
H N Rosen, A C Moses, J Garber, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 133) with videos related to
Sort By:
Page
of 14
Endocrinology
|
June 1, 1983
Changes in tissue concentrations of thyrotropin, free thyrotropin beta, and alpha-subunits after thyroxine administration: comparison of mouse hypothyroid pituitary and thyrotropic tumors
D S Ross, M F Downing, W W Chin, et al.
Journal of Surgical Oncology
|
September 1, 1983
Gut-associated lymphoid tissue and dimethylhydrazine-induced colorectal carcinoma in the Wistar/Furth rat
J M Deasy, G Steele, D S Ross, et al.
Endocrinology
|
November 1, 1983
Mouse pituitary tumor line secreting only the alpha-subunit of the glycoprotein hormones: development from a thyrotropic tumor
E C Ridgway, J D Kieffer, D S Ross, et al.
Surgery
|
November 1, 1990
Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements
J A Riseman, W A Zamboni, A Curtis, et al.
Calcified Tissue International
|
November 4, 1998
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates
H N Rosen, A C Moses, J Garber, et al.
The Journal of Biological Chemistry
|
December 25, 1983
Regulation by thyroxine of the mRNA encoding the alpha subunit of mouse thyrotropin
M A Shupnik, W W Chin, D S Ross, et al.
Radiology
|
June 1, 1993
Fine-needle biopsy of cervical lymph nodes in patients with thyroid cancer: a prospective comparison of cytopathologic and tissue marker analysis
M J Lee, D S Ross, P R Mueller, et al.
JBI Evidence Implementation
|
December 28, 2023
Factors that influence the implementation of innovation in aged care: a scoping review
Alice Windle, Amy Marshall, Lenore de la Perrelle, et al.
Calcified Tissue International
|
February 1, 2000
Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy
H N Rosen, A C Moses, J Garber, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 14, 1998
Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate
H N Rosen, A C Moses, J Garber, et al.
Page
of 14